Literature DB >> 7555918

Aging, caffeine, and information processing: an event-related potential analysis.

M M Lorist1, J Snel, G Mulder, A Kok.   

Abstract

Structural and energetic processes in information processing were studied in young and elderly subjects. A visually focussed selective search task was used, in which subjects had to select relevant information, followed by controlled memory search processes to locate a target item. Caffeine was used to manipulate the energetic state of the subjects. During task performance event-related potentials (ERPs) and reaction time (RT) were recorded. Subjects were 15 young and 15 elderly healthy, non-smoking, moderate caffeine consumers (250-600 mg/day). Before the experimental sessions they abstained from caffeine for > or = 12 h. In the experiment subjects received 250 mg caffeine or placebo dissolved in decaffeinated coffee. RT data seem to indicate that aging effects are at least partly due to a shift in the speed-accuracy trade-off. ERP results provide evidence for decreased levels of energy resources in the elderly. The identification of relevant information and stimulus evaluation processes were delayed in the elderly, suggesting an additional effect of aging on structural processes. Caffeine improved performance and increased the amplitude of the N1, N2b, and P3b, in both young and old subjects. These results suggest that caffeine makes more energy resources available for task performance. The effects of aging on P3b latency were counteracted by caffeine. Other caffeine effects did not differ significantly between young and elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555918     DOI: 10.1016/0168-5597(95)00069-5

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  9 in total

1.  Perceptual load, voluntary attention, and aging: an event-related potential study.

Authors:  Yan Wang; Shimin Fu; Pamela Greenwood; Yuejia Luo; Raja Parasuraman
Journal:  Int J Psychophysiol       Date:  2012-01-14       Impact factor: 2.997

Review 2.  Attention, psychomotor functions and age.

Authors:  Konrad Wolfgang Kallus; Jeroen A J Schmitt; David Benton
Journal:  Eur J Nutr       Date:  2005-12       Impact factor: 5.614

3.  Acute caffeine effect on repeatedly measured P300.

Authors:  J Pan; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-04       Impact factor: 3.674

4.  The effect of caffeine ingestion on functional performance in older adults.

Authors:  M J Duncan; N D Clarke; J Tallis; L Guimarães-Ferreira; S Leddington Wright
Journal:  J Nutr Health Aging       Date:  2014-12       Impact factor: 4.075

Review 5.  Caffeine and the elderly.

Authors:  L K Massey
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

6.  Effects of morning caffeine' ingestion on mood States, simple reaction time, and short-term maximal performance on elite judoists.

Authors:  Makram Souissi; Salma Abedelmalek; Hamdi Chtourou; Rim Atheymen; Ahmed Hakim; Zouhair Sahnoun
Journal:  Asian J Sports Med       Date:  2012-09

7.  Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson's disease according to task demands.

Authors:  Kanch Sharma; Sean James Fallon; Thomas Davis; Scott Ankrett; Greg Munro; Gary Christopher; Elizabeth Coulthard
Journal:  Psychopharmacology (Berl)       Date:  2022-01-10       Impact factor: 4.530

8.  Assessment of the ergogenic effect of caffeine supplementation on mood, anticipation timing, and muscular strength in older adults.

Authors:  Jason Tallis; Michael J Duncan; Sheila Leddington Wright; Emma L J Eyre; Elizabeth Bryant; Dominic Langdon; Rob S James
Journal:  Physiol Rep       Date:  2013-08-29

9.  A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee.

Authors:  David A Camfield; Beata Y Silber; Andrew B Scholey; Karen Nolidin; Antionette Goh; Con Stough
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.